Regucalcin has been shown to suppress the gene expression of cell-cycle-related proteins in proliferating cancer cells [25,79], including cdc2, cdk2m, chk2 (checkpoint kinase 2), and p21 mRNAs [80,81,82,83,84]. Here, RGN is linked to cancer.